miR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1

Background: The breast epithelial cells in patients with triple-negative breast cancer (TNBC) actually have specific estrogen receptor (ER) expression, and the abnormal glycosylation of UGT1A1 in TNBC cells resulted in abnormal expression and function of ERα through regulating the modification of ER...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Li, Yan, Zhou, Yidong, Mao, Feng, Shen, Songjie, Zhao, Bin, Xu, Yali, Lin, Yan, Zhang, Xiaohui, Cao, Xi, Xu, Ying, Chen, Chang, Zhang, Jinqian, Sun, Qiang
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479224/
https://ncbi.nlm.nih.gov/pubmed/32983995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01509
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados